Effervescent tablets dissolve fast in liquids, releasing carbon dioxide. The tablet instantly dissolves into a bubbly solution. These pills administer many drugs. These medications offer benefits. Because medications are readily absorbed, tablets deliver them to the body.
Convenience, expanding demand for nutritional supplements, medicinal uses, and the OTC sector drive effervescent tablet market share. Some effervescent tablets have side effects when used in high amounts, restricting market expansion. The Global Effervescent Tablet Market is limited by the high cost of manufacturing effervescent tablets, which makes them unaffordable for many.
Immune-boosting vitamin C is well-known. Consumers choose effervescent vitamin C tablets for their taste and convenience. Effervescent vitamin C tablets are preferred to capsules or tablets because they dissolve in water to form a tasty drink. Multivitamins are popular vitamin and mineral supplements. Effervescent multivitamin tablets make meeting daily nutritional needs easy and enjoyable. The Council for Responsible Nutrition's 2021 Annual Survey on Dietary Supplements found that US supplement consumption is at an all-time high. The study found that 76% of Americans will use dietary supplements in 2021, up from 74% in 2020. This shows the rising interest in and dependency on dietary supplements to improve health. Boosting the effervescent tablet market.
However, Effervescent tablet manufacture is expensive due to specific equipment, ingredient control, and packaging requirements. Granulation, mixing, tablet compression, and packing can increase production costs. Pharmaceutical and nutraceutical products, especially effervescent tablets, need several costs for raw materials, equipment, staff, quality control, and regulatory compliance. Effervescent tablets may cost more than other dosage forms due to their complexity and need for specialist equipment. Due to the additional processing steps required to produce the effervescent reaction and ensure tablet disintegration, effervescent tablets may cost more than conventional tablets or capsules, according to a study in 'Pharmaceuticals.'
Effervescent tablet formulation allows manufacturers to combine vitamins and minerals carefully for specific health conditions or demographic groupings. Children's formulas may contain more growth-promoting vitamins. Older adult formulas may include vitamins and minerals that support bone health and cognition. Effervescent pills allow adding functional ingredients, including herbal extracts, amino acids, antioxidants, and electrolytes, to increase health benefits. These formulas attract clients seeking comprehensive health support in a single, uncomplicated dosage. Manufacturers may leverage consumer desires for fun and delicious supplements by offering fruity, zesty, or herbal flavors. By modifying the flavor profile, effervescent multivitamins, and mineral tablets can appeal to more customers. Finally, product formulation innovation drives markets.
North America will dominate the effervescent tablet market at a CAGR of 6.86%. Chronic diseases and important market players drive regional growth. The CDC reported 1,603,844 new cancer cases and 602,347 cancer deaths in 2020. Four hundred three new cancer cases and 144 fatalities per 100,000 individuals. Drugs and supplements are FDA-regulated. Effervescent dietary supplements must fulfill FDA guidelines. FDA safety and quality standards affect North American market access and growth. The region's aging population and new product launches boost market revenue.
Asia Pacific's health consciousness is expected to grow at a CAGR of 7.56%. The local population is more health-conscious. Health-conscious consumers are seeking dietary supplements. Effervescent vitamins are convenient and entertaining, and meet the growing need for health and wellness products. The CFDA, India's Ministry of Health and Family Welfare, and Japan's PMDA regulate dietary supplements and medicines, including effervescent tablets. These rules safeguard product safety and quality for producers.
The key players in the global Effervescent tablet market are Bayer AG, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Perrigo Company plc, Reckitt Benckiser Group PLC, GSK plc, CHIESI SAS, Hermes Pharma, S. G. Biopharm Pvt. Ltd, Bliss GVS Pharma Limited, Alpex, Vovantis Laboratories, Swisse Wellness PTY LTD, Herbalife International of America Inc., SciTech, Nuun, Natur Produkt Zdrovit Sp Z O O, and Vitabiotics Ltd.